Clinical trials: Magnesium Deficiency
Magnesium Deficiency
Effectiveness of Qualia Magnesium+® Supplementation on RBC Magnesium Levels
This is a double-blind, placebo-controlled parallel trial designed to evaluate the effectiveness of Qualia Magnesium+® supplementation on red blood cell (RBC) magnesium levels in adults aged 21 and older.
- Trial name
- NCT06979648
- Testing
- Qualia Magnesium+®
- Where
- United States
- Volunteers
- 72 people, healthy volunteers welcome
- Sponsor
- Qualia Life Sciences
HIV Infections
A Pharmacokinetic Study to Evaluate the Effect of MAALOX on Raltegravir (MK-0518) in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-295)
This study evaluated the effect of single doses of a magnesium/aluminum antacid (MAALOX) given 4 and 6 hours before or after administration of raltegravir, on the pharmacokinetics of raltegravir in human immunodeficiency virus…
- Trial name
- NCT01930045
- Testing
- Raltegravir (ISENTRESS™), MAALOX (MAL)
- Volunteers
- 18 people
- Sponsor
- Merck Sharp & Dohme LLC
Healthy, Magnesium Deficiency
Bioavailability of Magnesium Supplements
The primary objective of this clinical trial is to demonstrate the superiority of Natural Calm magnesium powder with respect to absorption when compared to three marketed forms of magnesium (two magnesium bisglycinate powders and…
- Trial name
- NCT03353636
- Testing
- Magnesium
- Where
- Canada
- Volunteers
- 12 people, healthy volunteers welcome
- Sponsor
- Natural Calm Canada
Magnesium Deficiency, Stress, Psychological
Mineral Water Rich in Magnesium and Perceived Stress in Healthy Consumers
The goal of clinical trial is to evaluate the effect of one month of consumption of mineral water rich in magnesium or not on perceived stress, duration and quality of sleep in healthy consumers having magnesium daily intakes…
- Trial name
- STRESSOM15 (NCT02719925)
- Testing
- Mg(+), Mg(-)
- Where
- France
- Volunteers
- 256 people, healthy volunteers welcome
- Sponsor
- My Goodlife SAS
Cytomegalovirus Infections, HIV Infections
Safety and Efficacy of Intravenous Magnesium Sulfate in Modulating Changes in Symptoms and Divalent Cation Levels Associated With Foscavir Therapy: A Phase IV Randomized, Double-Blind, Placebo-Controlled, Cross-Over, Pilot Study
To determine whether acute ionized hypomagnesemia and hypocalcemia immediately following foscarnet infusions can be lessened or eliminated by prior infusion of magnesium sulfate.
- Conditions
- Cytomegalovirus Infections, HIV Infections, Hypocalcemia
- Trial name
- NCT00002146
- Testing
- Magnesium sulfate, Foscarnet sodium
- Where
- United States
- Volunteers
- 12 people
- Sponsor
- Astra USA